Industry News
-
Sangamo Files for Chapter 11 as Lilly and Astellas Move to Acquire Key Gene Therapy Assets
Jun 25 2026 -
REGENXBIO Plans Accelerated Approval Filing for RGX-202 AAV8 Gene Therapy in Duchenne Muscular Dystrophy
Jun 25 2026 -
Korean Research Consortium Targets 2029 Clinical Studies for Inherited Retinal Disease Gene Therapy
Jun 23 2026 -
Serapha Bio Launches with $230M to Advance In Vivo Base Editing Therapy for Alpha-1 Antitrypsin Deficiency
Jun 23 2026 -
AAV9 Gene Therapy Restores FMRP and Improves Brain Function in Fragile X Mouse Model
Jun 22 2026 -
Genprex Receives Canadian Patent Allowance for Quaratusugene Ozeplasmid Combination Therapy in Lung Cancer
Jun 22 2026 -
First Patient Receives AAV9 Gene Therapy for Cockayne Syndrome Through Parent-Led Development Effort
Jun 22 2026 -
CARsgen’s Cell Therapy Becomes World’s First Approved CAR-T Therapy for Solid Tumors
Jun 22 2026 -
REGENXBIO Aligns with FDA on Accelerated Approval Pathway for Gene Therapy in Hunter Syndrome
Jun 22 2026